Home > Insider Trading > Filing (0001209191-10-047487)

Filing Details

Accession Number:: 0001209191-10-047487
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-09-24 21:19:09
Reporting Period:: 2010-09-24

Filing Date:: 2010-09-24
Accepted Time:: 2010-09-24 21:19:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1484729	Rachel A. Leheny	C/O Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward CA 94545		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-09-24	250,000	$3.00	1,423,896	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Purchase Warrant	Acquisiton	2010-09-24	100,000	$0.00	100,000	$3.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,000	2010-09-24	2015-09-24	No	4	P	Indirect

Footnotes

Represents a price per unit purchased in connection with a private offering under the terms of that certain Securities Purchase Agreement, dated September 20, 2010, between the Issuer and certain investors identified therein. Each unit consisted of one (1) share of common stock of the Issuer and a warrant to purchase 0.40 shares of common stock of the Issuer.
These securities are held by Caxton Advantage Life Sciences Fund, L.P. The Reporting Person is (i) a Managing Director of Caxton Advantage Venture Partners, L.P., which is the General Partner of Caxton Advantage Life Sciences Fund, L.P. and (ii) a member of Advantage Life Sciences Partners LLC. Caxton Advantage Venture Partners, L.P. has voting and investment power with respect to such shares. Decisions by Caxton Advantage Venture Partners, L.P. with respect to such shares are made by Advantage Life Sciences Partners, LLC, the Managing General Partner of Caxton Advantage Venture Partners, L.P., together with the investment committee of Caxton Advantage Venture Partners, L.P. (continued in Footnote 3)
The Reporting Person has the authority to take action on behalf of Advantage Life Sciences Partners, LLC as a member of Advantage Life Sciences Partners, LLC. The Reporting Person disclaims beneficial ownership, except to the extent of her proportionate pecuniary interest, either directly, or indirectly through Caxton Advantage Venture Partners, L.P. (or through any other entity which is a limited partner in Caxton Advantage Life Sciences Fund, L.P.), in Caxton Advantage Life Sciences Fund, L.P.